Anagram Therapeutics, Inc.

This study is testing whether a new enzyme therapy called ANG003 works as well as the standard treatment (Creon) for people with cystic fibrosis who have trouble digesting food. About 113 participants aged 12+ with cystic fibrosis and severe pancreatic insufficiency will try eith…